← Back to Search

Phaeosol group for Dietary Supplement (PHAEOSOL-ONE Trial)

N/A

Waitlist Available

Led By Richard B. Kreider

Research Sponsored by Microphyt

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 and 12 weeks

Awards & highlights

PHAEOSOL-ONE Trial Summary

This trial will study whether taking a dietary supplement made from an extract of the microalgae Phaeodactylum tricornutum with a nutrient called Fucoxanthin can help women better manage their weight when combined with exercise.

Eligible Conditions

Dietary Supplement
Weight Changes
Obesity
Healthy Lifestyle
Exercise

PHAEOSOL-ONE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 and 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 and 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Body fat mass (in % of total body weight)

Body fat mass (in Kg)

Secondary outcome measures

Blood ALT level (U/l)

Blood AST level (U/l)

Creatinine

+25 more

PHAEOSOL-ONE Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Phaeosol groupExperimental Treatment1 Intervention

Daily supplementation of Phaeosol softgel capsule (218mg/d), active ingredients of Microphyt. Each randomized subject will consume 1 softgel capsule (before breakfast) per day during 12 weeks

Group II: Placebo groupPlacebo Group1 Intervention

Daily supplementation of placebo softgel capsule (218mg/d of 100% sunflower oil) with the same appearance and packaging than experimental product. Each randomized subject will consume 1 softgel capsule (before breakfast) per day during 12 weeks

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Phaeosol group

2021

N/A

~60

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Texas A&M UniversityOTHER

139 Previous Clinical Trials

23,855 Total Patients Enrolled

MicrophytLead Sponsor

4 Previous Clinical Trials

246 Total Patients Enrolled

1 Trials studying Dietary Supplement

66 Patients Enrolled for Dietary Supplement

Richard B. KreiderPrincipal InvestigatorExercise & Sport Nutrition Lab - Texas A&M University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are seniors above the age of 55 able to participate in this research?

"This research project requires that participants are at least 18 and no older than 50 years of age to be eligible for enrollment."

Answered by AI

Is there still an opportunity to be involved in this clinical exploration?

"Candidates between 18 and 50 years old, with significant changes in weight, may be eligible for selection. This medical trial is looking to recruit a total of 60 individuals."

Answered by AI

How many individuals are taking part in this research initiative?

"Affirmative. According to the information provided on clinicaltrials.gov, this research study is presently recruiting participants who fit its criteria. The trial was first posted on April 26th 2021 and has most recently been updated on February 23rd 2023; it seeks 60 volunteers at a single medical site."

Answered by AI

Are there any opportunities presently available for individuals to participate in this experiment?

"Affirmative. The clinical trial page on clinicaltrials.gov affirms that the investigation is actively recruiting participants, with its first posting made on April 26th 2021 and revised as recently as February 23rd 2023. 60 subjects are required to be enrolled from a single research site."

Answered by AI

What is the primary aim of this endeavor?

"As per the study backer, Microphyt, body fat mass (as a proportion of total body weight) will be measured over 6 and 12 week intervals. Secondary outcomes such as oxygen uptake capacity fluctuation compared to baseline values at weeks 6 & 12, TNFa levels in the blood relative to baseline data points, and INF concentrations throughout this period are also being assessed."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Microalgae Extract Phaeosol Combined to Exercise in Healthy Overweight Women : Efficacy on Body Weight Management

2021. "Microalgae Extract Phaeosol Combined to Exercise in Healthy Overweight Women : Efficacy on Body Weight Management". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04761406.